drugset / Trial / NCT00725036
Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Oceania. The aim of this trial is to compare the safety of using pulmonary inhaled human insulin to s.c. insulin aspart both combined with NPH insulin in subjects with type 1 diabetes.
Timeline
- Start
- 2002-09-02
- Primary completion
- 2004-12-14
- Completion
- 2004-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Inhaled |
| Subject | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |
| Background | insulin NPH | Protein / enzyme biologic | — | — |